Content
FDA approved for more than 25 years
Ever heard the term “terminal hair” from a healthcare professional and thought, “Is my hair dying? Are they talking about hair loss?”
Don’t worry. Terminal hairs aren’t dying hair follicles. Terminal hair is just the name for the dark, thick strands that grow on your head — and other parts of your body after puberty.
But if you’re worried about hair loss? You might want to keep an eye out for changes in your terminal hairs.
Below, we cover what terminal hairs are, where they usually grow, and what to look for if you’re concerned about male pattern baldness.
Content
Terminal hair is the thick, coarse hair you see on your head, pubic area, and other parts of the body. It serves as a protective layer for your skin.
This type of hair has three parts:
The medulla (the core)
The melanin-containing cortex (gives hair its color)
The cuticle (protective outer layer)
Most hair starts off as fine, light vellus hair follicles. However, during puberty, men start growing darker, pigmented terminal hair due to hormonal changes.
The amount and location of terminal hair are influenced by your gender at birth. Typically, females have terminal hair covering about 30 percent of their body, while males can have up to 90 percent coverage. The difference is driven by male sex hormones called androgens, especially testosterone.
Before terminal hair, there’s vellus hair — also known as peach fuzz. These fine, soft hairs are present from birth and cover our bodies. They’re usually colorless and nearly invisible to the naked eye.
In childhood, they cover your upper lip, underarms, and pubic areas.
As you age, some vellus hair follicles turn into terminal hairs, but many remain. You’ll usually have them on parts of your face without a beard and around your ears.
Terminal hair can grow anywhere on the human body. However, it’s more common in some areas than others.
Before puberty, terminal hair grows exclusively on the scalp, eyebrows, and eyelashes. Once puberty begins, vellus hairs on other parts of the body will start to change into terminal hairs.
Terminal hair growth during and after puberty is most common on the following areas:
Armpits
Pubic region
Face
Chest
Legs
Arms
Hands
Feet
Fingers
Toes
Hair grows all over the human body, but some people may develop more terminal hairs during puberty due to hormone levels changing.
Men often see terminal hairs on their backs, buttocks, and shoulders. Your genetics and endocrine system largely influence where and how many terminal hairs you develop. Excess terminal hair growth is known as hirsutism.
While heavy terminal hair growth isn’t a health concern, some men opt for hair removal due to personal preference.
When women experience thicker hair growth, it’s often due to polycystic ovary syndrome.
Remember, the choice to keep or remove hair is entirely up to you!
Healthy hair isn’t a happy accident, it’s all about the right nutrients, regular washing, and protection from damage.
The following nutrients help support a healthy hair growth cycle:
Biotin
Vitamin E
Zinc
Omega-3 fatty acids
Your scalp hair and body hair need a balanced amount of natural oil, courtesy of your sebaceous glands, to shield them from damage.
Too little oil? Keratin in hair follicles can tangle, break, and turn dry and brittle. Excess hair oil? Say hello to greasy, flat hair and an increased risk of scalp issues and bacterial infections.
Excess sebum can also trap dirt and unwanted chemicals, leading to dandruff or folliculitis.
Other sources of hair damage that can weaken hair include:
UV rays
Excessive heat styling
Harsh chemicals
Male pattern baldness (AKA androgenetic alopecia) happens when a testosterone by-product called dihydrotestosterone (DHT) damages hair follicles, injuring the stem cells. This damage disrupts the hair growth cycle, leading to thinning and hair loss.
Hair grows in three stages: the anagen phase (growth), catagen phase (maturity), and telogen phase (resting phase).
In androgenic alopecia, DHT keeps hair follicles stuck in the resting phase, preventing new growth.
Unfortunately, once the damage is severe, you can’t reverse it. That’s why treatment options aim to protect remaining terminal hairs from further harm.
FDA-approved hair loss treatments like finasteride block DHT, while topical products like minoxidil foam and minoxidil solution promote healthy blood flow follicles along the hairline and crown.
Terminal hair sounds scary. But you don’t need to stress over this particular type of hair follicle. Everyone has some degree of terminal hairs covering their body.
Let’s recap what we know about this type of hair:
Terminal hairs are a natural part of your body from birth. You’ll grow more of these thicker, coarse hairs in adulthood.
Terminal hairs are what replaces the thin, peach fuzzy follicles that cover most of your body in childhood. Terminal hair on your face and body is largely influenced by your genetics and hormones.
Androgenic alopecia causes terminal hair loss. If you’re worried about going bald, terminal hairs should be your focus.
A dermatology professional or other healthcare provider can help. Noticing hair thinning? A healthcare professional can recommend effective, FDA-approved hair loss medications like minoxidil and finasteride.
Have more questions? Want to know how to protect the terminal hairs that protect your head? Reach out today for a hair loss consultation with one of our hair loss experts.
Hims & Hers has strict sourcing guidelines to ensure our content is accurate and current. We rely on peer-reviewed studies, academic research institutions, and medical associations. We strive to use primary sources and refrain from using tertiary references. See a mistake? Let us know at [email protected]!
This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for and should never be relied upon for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment. Learn more about our editorial standards here.
Dr. Knox Beasley is a board certified dermatologist specializing in hair loss. He completed his undergraduate studies at the United States Military Academy at West Point, NY, and subsequently attended medical school at Tulane University School of Medicine in New Orleans, LA.
Dr. Beasley first began doing telemedicine during his dermatology residency in 2013 with the military, helping to diagnose dermatologic conditions in soldiers all over the world.
Dr. Beasley is board certified by the American Board of Dermatology, and is a Fellow of the American Academy of Dermatology.
Originally from Nashville, TN, Dr. Beasley currently lives in North Carolina and enjoys spending time outdoors (with sunscreen of course) with his wife and two children in his spare time.
Bachelor of Science, Life Sciences. United States Military Academy.
Doctor of Medicine. Tulane University School of Medicine
Dermatology Residency. San Antonio Uniformed Services Health Education Consortium
Board Certified. American Board of Dermatology
Wilson, L. M., Beasley, K. J., Sorrells, T. C., & Johnson, V. V. (2017). Congenital neurocristic cutaneous hamartoma with poliosis: A case report. Journal of cutaneous pathology, 44(11), 974–977. https://onlinelibrary.wiley.com/doi/10.1111/cup.13027
Banta, J., Beasley, K., Kobayashi, T., & Rohena, L. (2016). Encephalocraniocutaneous lipomatosis (Haberland syndrome): A mild case with bilateral cutaneous and ocular involvement. JAAD case reports, 2(2), 150–152. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867906/
Patterson, A. T., Beasley, K. J., & Kobayashi, T. T. (2016). Fibroelastolytic papulosis: histopathologic confirmation of disease spectrum variants in a single case. Journal of cutaneous pathology, 43(2), 142–147. https://onlinelibrary.wiley.com/doi/10.1111/cup.12569
Beasley, K., Panach, K., & Dominguez, A. R. (2016). Disseminated Candida tropicalis presenting with Ecthyma-Gangrenosum-like Lesions. Dermatology online journal, 22(1), 13030/qt7vg4n68j. https://pubmed.ncbi.nlm.nih.gov/26990472/
Kimes, K., Beasley, K., & Dalton, S. R. (2015). Eruptive milia and comedones during treatment with dovitinib. Dermatology online journal, 21(9), 13030/qt8kw141mb. https://pubmed.ncbi.nlm.nih.gov/26437285/
Miladi, A., Thomas, B. C., Beasley, K., & Meyerle, J. (2015). Angioimmunoblastic t-cell lymphoma presenting as purpura fulminans. Cutis, 95(2), 113–115. https://pubmed.ncbi.nlm.nih.gov/25750965/
Beasley K, Dai JM, Brown P, Lenz B, Hivnor CM. (2013). Ablative Fractional Versus Nonablative Fractional Lasers – Where Are We and How Do We Compare Differing Products?. Curr Dermatol Rep, 2, 135–143. https://idp.springer.com/authorize?response_type=cookie&client_id=springerlink&redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs13671-013-0043-0
Siami P, Beasley K, Woolen S, Zahn J. (2012). A retrospective study evaluating the efficacy and tolerability of intra-abdominal once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancer. UroToday Int J, June 5(3), art 26. https://www.urotoday.com/volume-5-2012/vol-5-issue-3/51132-a-retrospective-study-evaluating-the-efficacy-and-tolerability-of-intra-abdominal-once-yearly-histrelin-acetate-subcutaneous-implants-in-patients-with-advanced-prostate-cancer.html
Siami P, Beasley K. (2012). Dutasteride with As-Needed Tamsulosin in Men at Risk of Benign Prostate Hypertrophy Progression. UroToday Int J, Feb 5(1), art 93. https://www.urotoday.com/volume-5-2012/vol-5-issue-1/48691-dutasteride-with-as-needed-tamsulosin-in-men-at-risk-of-benign-prostatic-hypertrophy-progression.html